1255098

Michael Luhua Wang, M.D. — FEI 3011409903

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 5, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)